Kimberly-Clark Earnings Reports

The company posted robust organic growth and maintained profitability despite pricing pressures and currency impacts. Adjusted EPS slightly declined year-over-year, but strong operational execution contributed to high margins and improved cash returns.

Kimberly-Clark saw Q1 2025 revenue fall by 6% to $4.84 billion due to currency impacts and divestitures, though strong productivity and innovation helped mitigate profit pressures. Adjusted EPS came in at $1.93, while net income totaled $567 million.

Kimberly-Clark reported Q4 2024 results with net sales of $4.9 billion, a decrease of 0.8%, but organic sales grew by 2.3%. Adjusted EPS was $1.50, down 0.7% year-over-year. The company's Powering Care strategy drove volume gains and improved product mix, generating significant efficiencies.

Kimberly-Clark reported Q3 2024 net sales of $5.0 billion, a 4% decrease compared to the prior year, but organic sales grew by 1%. Adjusted EPS increased by 5% to $1.83. The company reaffirmed its 2024 profit outlook, expecting organic net sales to grow between 3-4%.

Kimberly-Clark reported Q2 2024 net sales of $5.0 billion, a 2% decrease compared to the prior year, but organic sales grew by 4%. Adjusted EPS increased by 19% to $1.96, driven by organic growth and productivity gains. The company raised its 2024 earnings outlook, expecting mid-to-high teens percentage rate growth in adjusted operating profit and adjusted earnings per share on a constant-currency basis.

Kimberly-Clark reported net sales of $5.1 billion, a 1% decrease, but organic sales grew by 6%. Diluted EPS increased by 14% to $1.91, and adjusted EPS rose by 20% to $2.01. The company has raised its 2024 outlook to reflect this solid start.

Kimberly-Clark's Q4 2023 net sales were $5.0 billion, in line with the prior year, with organic sales up 3 percent. Diluted EPS was $1.50, and adjusted EPS was $1.51, down 2 percent versus the prior year. The company's full-year net sales reached $20.4 billion, a 1 percent increase, with organic sales up 5 percent.

Kimberly-Clark reported a strong third quarter in 2023, with net sales up 2% to $5.1 billion and organic sales growth of 5%. The company's gross margin improved significantly, and adjusted earnings per share increased by 24%. Based on year-to-date performance, Kimberly-Clark raised its full-year outlook.

Kimberly-Clark's second quarter 2023 results showed a 1% increase in net sales to $5.1 billion, with organic sales up 5%. The company's gross margin was 33.7%, a 350 basis point increase, and adjusted EPS was $1.65. Due to the strong first-half performance, Kimberly-Clark raised its full-year outlook for organic sales growth to 3-5% and adjusted EPS growth to 10-14%.

Kimberly-Clark reported a strong start to 2023, with a 2% increase in net sales to $5.2 billion and a 5% increase in organic sales. The company's gross margin improved by 340 basis points, and diluted earnings per share increased by 8% to $1.67. The company raised its 2023 outlook for adjusted earnings per share growth.

Kimberly-Clark reported Q4 2022 net sales of $5.0 billion, consistent with the year-ago period, and a 5% increase in organic sales. Diluted net income per share was $1.50, up from $1.06 in 2021, with adjusted earnings per share at $1.54, an 18% increase. The company's operating profit rose to $712 million from $521 million, driven by higher net selling prices and cost savings.

Kimberly-Clark's Q3 2022 results showed a slight increase in net sales, driven by organic sales growth, but adjusted earnings per share declined due to higher input costs and other factors. The company is maintaining its full-year organic sales growth target and expects adjusted earnings per share to be at the lower end of the provided range.

Kimberly-Clark's Q2 2022 net sales increased by 7% to $5.1 billion, with organic sales growth of 9%. Diluted net income per share was $1.29, and adjusted earnings per share were $1.34, a 9% decrease compared to the previous year. The company is targeting full-year 2022 organic sales growth of 5 to 7 percent and maintains adjusted earnings per share range of $5.60 to $6.00.

Kimberly-Clark's first quarter 2022 results showed a 7% increase in net sales to $5.1 billion, including 10% organic sales growth. Diluted net income per share was $1.55, while adjusted earnings per share were $1.35, a decrease of 25% compared to the previous year. The company updated its full-year 2022 organic sales growth target to 4-6% and expects adjusted earnings per share of $5.60 to $6.00.

Kimberly-Clark reported a 3% increase in net sales to $5.0 billion for Q4 2021, with organic sales also up by 3%. Diluted net income per share was $1.06, and adjusted earnings per share were $1.30, a decrease of 23% compared to the previous year. The company's 2022 outlook includes an expected net sales increase of 1-2% and organic sales growth of 3-4%.

Kimberly-Clark Corporation reported a 7% increase in net sales to $5.0 billion, driven by organic sales growth, but experienced a decrease in adjusted earnings per share to $1.62 due to significant inflation and supply chain disruptions.

Kimberly-Clark reported a 2% increase in net sales to $4.7 billion, driven by foreign currency and the Softex Indonesia acquisition, but organic sales declined by 3%. Diluted net income per share was $1.19, and adjusted earnings per share were $1.47, both down from the previous year. The company is facing significantly higher input costs and reduced consumer tissue volumes.

Kimberly-Clark reported a 5% decrease in net sales to $4.7 billion, including an 8% organic sales decline. Diluted net income per share was $1.72, and adjusted earnings per share were $1.80. The company is updating its full-year 2021 organic sales growth target to 0-1% and adjusted earnings per share to $7.30-$7.55.

Kimberly-Clark's Q4 2020 net sales increased by 6% to $4.8 billion, including a 5% organic sales growth. Diluted net income per share was $1.58, and adjusted earnings per share were $1.69. The company expects net sales to increase 4 to 6 percent in 2021.

Kimberly-Clark reported a 1% increase in net sales to $4.7 billion, driven by a 3% organic sales growth. Adjusted earnings per share were $1.72, and the company is raising its full-year outlook, expecting adjusted earnings per share to grow 9 to 11 percent this year.

Kimberly-Clark Corporation reported second quarter 2020 results with net sales of $4.6 billion, a slight increase compared to the year-ago period. Organic sales grew by 4 percent. Diluted net income per share was $1.99, and adjusted earnings per share were $2.20, up 32 percent compared to the previous year. The company is restoring financial guidance for full-year 2020 and restarting its share repurchase program.

Kimberly-Clark's first quarter 2020 results showed an 8% increase in net sales to $5.0 billion compared to the previous year, with organic sales growth of 11%. Diluted net income per share was $1.92, and adjusted earnings per share were $2.13, a 28% increase. Cash provided by operations was $704 million. Due to the uncertainty related to the COVID-19 pandemic, the company is withdrawing its previous full-year 2020 financial outlook.

Kimberly-Clark reported fourth-quarter net sales of $4.6 billion, consistent with the previous year, with a 3% increase in organic sales. Diluted net income per share was $1.59, and adjusted earnings per share were $1.71, a 7% increase. The company anticipates a 1% net sales increase in 2020, including 2% organic sales growth.